AKT1 and hepatocellular carcinoma: Moreover, AZD5363 suppresses the proliferation of human HCC cell lines, HepG2 and Huh-7, by inhibiting the phosphorylation of downstream molecules in the Akt signal pathway in a dose- and time-dependent manner [67].